Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Treatment, Prospective, Assignment, Open Label, Single-center, Non-randomized Study An
exploratory clinical trial of comparison of Nab-Paclitaxel combined with Gemcitabine and
Gemcitabine combined with Tegafur for adjuvant chemotherapy after radical resection of
pancreatic cancer